This process ultimately identified six potential genes that significantly affect the diagnosis of AIS in NAFLD patients: CEBPD, SOCS2, THBS1, IFIT2, TNFSF10, and IL2RB. This evidence concerns the gene THBS1 and metabolic dysfunction-associated steatotic liver disease.